Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.

Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF, Eeles RA, Kote-Jarai Z.

Br J Cancer. 2016 Apr 12;114(8):945-52. Erratum in: Br J Cancer. 2018 Feb 13;:.

2.

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.

Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, Aly M, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, Mcdonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokołorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Arndt V, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Govindasami K, Guy M, Lophatonanon A, Muir K, Viñuela A, Brown AA; PRACTICAL Consortium; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; Australian Prostate Cancer BioResource; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators, Freedman M, Conti DV, Easton D, Coetzee GA, Eeles RA, Kote-Jarai Z.

Hum Mol Genet. 2015 Oct 1;24(19):5589-602. doi: 10.1093/hmg/ddv203. Epub 2015 May 29.

3.

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.

Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, Ostrander EA, Ingles SA, John EM, Thibodeau SN, Schaid D, Park JY, Spurdle A, Clements J, Dickinson JL, Maier C, Vogel W, Dörk T, Rebbeck TR, Cooney KA, Cannon-Albright L, Chappuis PO, Hutter P, Zeegers M, Kaneva R, Zhang HW, Lu YJ, Foulkes WD, English DR, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Saunders EJ, Page EC, Sawyer EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Southey MC, Lophatananon A, Liu JF, Kolonel LN, Le Marchand L, Wahlfors T, Tammela TL, Auvinen A, Lewis SJ, Cox A, FitzGerald LM, Koopmeiners JS, Karyadi DM, Kwon EM, Stern MC, Corral R, Joshi AD, Shahabi A, McDonnell SK, Sellers TA, Pow-Sang J, Chambers S, Aitken J, Gardiner RA, Batra J, Kedda MA, Lose F, Polanowski A, Patterson B, Serth J, Meyer A, Luedeke M, Stefflova K, Ray AM, Lange EM, Farnham J, Khan H, Slavov C, Mitkova A, Cao G; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF.

Nat Genet. 2009 Oct;41(10):1116-21. doi: 10.1038/ng.450. Epub 2009 Sep 20.

4.

Multiple loci on 8q24 associated with prostate cancer susceptibility.

Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, Leongamornlert DA, Tymrakiewicz M, Jhavar S, Saunders E, Hopper JL, Southey MC, Muir KR, English DR, Dearnaley DP, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Sawyer E, Lophatananon A; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK Prostate testing for cancer and Treatment study (ProtecT Study) Collaborators, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper C, Donovan JL, Hamdy FC, Neal DE, Eeles RA, Easton DF.

Nat Genet. 2009 Oct;41(10):1058-60. doi: 10.1038/ng.452. Epub 2009 Sep 20.

PMID:
19767752
5.

Cardiac complications of radiation therapy.

Gaya AM, Ashford RF.

Clin Oncol (R Coll Radiol). 2005 May;17(3):153-9. Review.

PMID:
15900998
6.

Right ventricular outflow tract obstruction secondary to myocardial metastases from colorectal cancer.

Gaya MA, Randle A, Ashford RF.

Clin Oncol (R Coll Radiol). 2005 Feb;17(1):70-1. No abstract available.

PMID:
15714938
7.

Solitary bone plasmacytoma: management of isolated local relapse following radiotherapy.

Lewanski CR, Bates T, Bowen J, Ashford RF.

Clin Oncol (R Coll Radiol). 1999;11(5):348-51. Review.

PMID:
10591824
8.

Bone marrow involvement in breast cancer detected by positron emission tomography.

Lewanski CR, Kaplan GR, Potter J, Richman P, Ashford RF, Wong WL.

J R Soc Med. 1999 Apr;92(4):193-5. No abstract available.

9.

Sensitivity of the Jamar Dynamometer in detecting submaximal grip effort.

Ashford RF, Nagelburg S, Adkins R.

J Hand Surg Am. 1996 May;21(3):402-5.

PMID:
8724469
10.

The role of radiotherapy in carcinoma of the thoracic oesophagus: an audit of the Mount Vernon experience 1980-1989.

Leslie MD, Dische S, Saunders MI, Grosch E, Fermont D, Ashford RF, Maher EJ.

Clin Oncol (R Coll Radiol). 1992 Mar;4(2):114-8.

PMID:
1372818
11.

Experience with CHART.

Saunders MI, Dische S, Grosch EJ, Fermont DC, Ashford RF, Maher EJ, Makepeace AR.

Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):871-8. Erratum in: Int J Radiat Oncol Biol Phys 1991 Nov;21(6):1683.

PMID:
1651312
12.

An audit of head and neck cancer treatment in a Regional Centre for Radiotherapy and Oncology.

Hong A, Saunders MI, Dische S, Grosch E, Fermont D, Ashford RF, Maher EJ.

Clin Oncol (R Coll Radiol). 1990 May;2(3):130-7.

PMID:
1702015
13.

Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck region.

Saunders MI, Dische S, Hong A, Grosch EJ, Fermont DC, Ashford RF, Maher EJ.

Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1287-93.

PMID:
2689397
14.

Gastro-intestinal malignancy in association with Peutz-Jeghers syndrome--three further cases.

Stockdale AD, Ashford RF, Leader M.

Clin Oncol. 1984 Sep;10(3):299-301.

PMID:
6478687
15.

Conservative excision and radiotherapy for early breast cancer--an acceptable alternative?

Ashford RF, Phillips RH, Coe MA, Pickering DG, Baily B, Ellis H.

Clin Oncol. 1984 Mar;10(1):45-58.

PMID:
6705326
16.

A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract.

Smith BJ, Ashford RF, Bakowski M, Hellman K, Newton K, Phillips R, Lambert J, Jones R, Peters N, Evans M.

Am J Clin Oncol. 1983 Aug;6(4):481-4.

PMID:
6346856
17.

Isolated testicular relapse after bone marrow transplantation for acute lymphoblastic leukaemia.

Ashford RF, Cassoni AM, Bowcock S, Phillips RH, Kendra J, Joshi R, Barratt J.

Lancet. 1983 Jul 23;2(8343):228. No abstract available.

PMID:
6135067
18.

Nasal cartilage necrosis following high-dose 5-FU: a case report.

Ashford RF, Mughal T, Goold MA, Smith BJ, Phillips RH, MacKay IS.

Cancer Treat Rep. 1982 Oct;66(10):1884. No abstract available.

PMID:
7127331
19.

Radiation pneumonitis in a patient exposed to asbestos.

Ashford RF, Maher J, Drury A, Pickering D.

Br J Radiol. 1981 Jan;54(637):74-7. No abstract available.

PMID:
7448505
20.

Pyrexia after cisplatin.

Ashford RF, McLachlan A, Nelson I, Mughal T, Pickering D.

Lancet. 1980 Sep 27;2(8196):691-2. No abstract available.

PMID:
6106801

Supplemental Content

Loading ...
Support Center